EMEA-001710-PIP03-17-M01

Key facts

Active substance
Ozanimod
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0008/2020
PIP number
EMEA-001710-PIP03-17-M01
Pharmaceutical form(s)
  • Capsule, hard
  • Age-appropriate oral solid dosage form
Condition(s) / indication(s)
Treatment of ulcerative colitis
Route(s) of administration
Oral use
Contact for public enquiries
Celgene Europe Limited

Tel.+41 327298500
E-mail: medinfo.emea@celgene.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating